PureTech Health PLC at JPMorgan Healthcare Conference Transcript
So good morning. Welcome to the 42nd Annual JPMorgan Healthcare Conference. My name is Edwin Zhang. I'm a member of the JPMorgan healthcare team and the moderator for this session.
Today, I would like to introduce you to the team from PureTech Health. Please join me in welcoming our presenters, Daphne Zohar, Co-Founder and CEO; and Eric Elenko, Co-Founder.
Thanks so much, Edwin, and thank you to the JPMorgan team for inviting us to present today. Welcome to all of you who are joining us here in the room and those of you who are joining us via webcast. We're coming off of a very successful 2023 with strong clinical and strategic progress. And we're at a turning point this year for our company as we sharpen our focus on pulmonary and rare disease in our wholly owned pipeline and as we advance two new founded entities that we'll be saying more about in two important additional therapeutic areas.
We'll be making some forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |